Supplemental Annuity Collective Trust (SACT) of New Jersey’s AstraZeneca AZN Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,461	Closed	-$820K	–	303
2025 Q4	$820K	Sell	4,461 -850	-16%	-$149K	0.21%	106
2025 Q3	$815K	Hold	5,311	–	–	0.21%	106
2025 Q2	$742K	Hold	5,311	–	–	0.21%	113
2025 Q1	$781K	Hold	5,311	–	–	0.25%	103
2024 Q4	$696K	Hold	5,311	–	–	0.2%	112
2024 Q3	$827K	Hold	5,311	–	–	0.24%	101
2024 Q2	$828K	Hold	5,311	–	–	0.25%	96
2024 Q1	$720K	Hold	5,311	–	–	0.22%	114
2023 Q4	$715K	Hold	5,311	–	–	0.25%	111
2023 Q3	$719K	Hold	5,311	–	–	0.27%	108
2023 Q2	$760K	Hold	5,311	–	–	0.27%	104
2023 Q1	$737K	Hold	5,311	–	–	0.29%	105
2022 Q4	$720K	Hold	5,311	–	–	0.3%	99
2022 Q3	$582K	Hold	5,311	–	–	0.25%	114
2022 Q2	$702K	Hold	5,311	–	–	0.28%	104
2022 Q1	$705K	Hold	5,311	–	–	0.23%	128
2021 Q4	$619K	Hold	5,311	–	–	0.19%	149
2021 Q3	$638K	Buy	+5,311	New	+$618K	0.21%	138

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Supplemental Annuity Collective Trust (SACT) of New Jersey's AZN Position: Q1 2026 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 4,461 shares — an estimated $820K sold.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in AZN in Q3 2021 and held it in 18 quarters. The position peaked at $828K in Q2 2024. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Supplemental Annuity Collective Trust (SACT) of New Jersey reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Supplemental Annuity Collective Trust (SACT) of New Jersey sold 4,461 AstraZeneca shares in Q1 2026, an estimated $820K.
Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in AstraZeneca in Q3 2021 and held it in 18 quarters.
Supplemental Annuity Collective Trust (SACT) of New Jersey's AstraZeneca position peaked at $828K in Q2 2024.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q1 2026, filed 1 May 2026.